Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Sulfonylurea
36%
Metformin
35%
Diabetes
30%
Hemoglobin A1c (HbA1c)
29%
Precision Medicine
21%
Glycemic Response
18%
Insulin Resistance
16%
Dipeptidyl peptidase-4 (DPP-4)
14%
Monogenic Diabetes
14%
Glucagon-like
11%
Thiazolidinediones
11%
Hypoglycemia
11%
Glucose-lowering Drugs
11%
Glycaemic Deterioration
10%
Genotype
10%
Organic Cation Transporter 1
10%
Second-line Therapy
10%
β-cell Function
9%
Genetic Risk
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Type I Diabetes
9%
Genetic Variants
9%
Third-line Therapy
9%
Type 2 Diabetes Risk
9%
Type 2 Diabetic Patients
9%
Innovative Medicines Initiative
8%
Metformin Response
8%
Meta-analysis
8%
Gastrointestinal Tolerance
8%
Risk Factors
8%
Drug Response
7%
Patient Stratification
7%
Sitagliptin
7%
Pioglitazone
7%
Obesity
7%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
7%
Canagliflozin
7%
C-peptide
6%
SLCO1B1
6%
Pharmacogenetics
6%
Intolerance
6%
HbA1c Reduction
6%
Diabetes Progression
6%
Trial Data
6%
Clinical Markers
6%
Polygenic Score
5%
Mechanism of Action
5%
Metformin Intolerance
5%
Diabetes Management
5%
Gliclazide
5%
Rapid Progression
5%
Intolerant
5%
Urinary C-peptide Creatinine Ratio
5%
Diabetes Therapy
5%
Cytochrome P450 2C9 (CYP2C9)
5%
Clinical Practice Research Datalink
5%
Biomarker Testing
5%
Young-onset Diabetes
5%
Drug-gene Interaction
5%
Drug Class
5%
Diabetes Drugs
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
71%
Diabetes
64%
Glycon
51%
Genetics
23%
Glycemic
23%
Insulin
21%
Personalized Medicine
20%
Glucose
18%
Biological Marker
17%
Insulin Dependent Diabetes Mellitus
16%
Organic Cation Transporter 1
16%
Sulfonylurea
15%
Patient with Type 2 Diabetes
14%
Body Mass Index
14%
Diseases
14%
C-Peptide
13%
Cohort Analysis
12%
Hemoglobin A1c
12%
Insulin Resistance
11%
Allele
10%
Insulin Treatment
9%
Primary Health Care
8%
Beta Cell
8%
Cell Function
8%
Deterioration
8%
Glucagon Like Peptide 1
8%
Asian Indians
8%
Incretin
7%
Oral
7%
Autoantibodies
6%
Dipeptidyl Peptidase-4 Inhibitor
6%
Thiazolidinedione
6%
Lactic Acid
6%
Gastrointestinal Distress
5%
Creatinine
5%
Genetic Risk
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Biochemistry, Genetics and Molecular Biology
Maturity Onset Diabetes of the Young
92%
Glycemia
41%
Genetics
36%
Insulin
26%
Allele
21%
Sulfonylurea
20%
Glucose
20%
Genotyping
20%
Genetic Divergence
13%
Pharmacogenomics
12%
Glucagon-Like Peptide 1 Receptor
10%
Receptor Agonists
10%
Pharmacogenetics
10%
C-Peptide
10%
Polygenic Score
10%
Transporter Genes
9%
Tamsulosin
8%
Genome Wide Association Study
8%
Pharmacokinetics
8%
Transfer RNA
8%
Glucagon-Like Peptide-1
8%
Metabolite
7%
Prevalence
6%
Drug Mechanism
6%
Deficiency
5%
Cell Function
5%
Lipid
5%
CYP2C9
5%
Drug Response
5%
Methyltransferase
5%
Blood Plasma
5%
HNF1A
5%